Memphasys Ltd has released a press release.
Memphasys receives A$3.5 million from Peters Investments
Earlier from Memphasys
- Potential Expedited FDA Pathway to US IVF Market
- Memphasys Secures European Felix Agreement
- Felix Registration Achieved in Turkey, Sales Commence
- EUR526,500 Nordic Agreement Expands Felix European Footprint